Thursday, September 01, 2016 3:43:28 PM
I would also check out Organigram if you want to diversify a little bit between companies in the Canadian medical marijuana producer market. They also just finished a $23 million bought financing deal (approx $17,500 U.S.) and announced yesterday that they bought another adjoining 10 acres and existing 150k sq ft building on that land. They said production capacity will increase by up to 4X. The market cap on Organigram appears to be only $82,000,000 US vs about $155 million for Aurora. Both companies are currently only authorized to sell 3,500,000 grams of medical marijuana per year and they seem to be two of the lower-cost producers. I do think that considering both of their upcoming expansion of production capacity, Aurora is currently in a much stronger position huge growth as they'll eventually be able to produce (and likely sell) all of their 70,000,000 gram production capacity beginning mid-2018 whereas the best I can tell, Organigram's max production capacity will be around 19,000,000 grams as of now. Organigram also entered a licensing agreement for their oils and edibles today as well. Seems like it's been a pretty productive couple of weeks for Organigram...again, long term I like Aurora better but I think given the difference in market caps currently, I'll have more exposure to Organigram for the short-term and then roll those into shares of Aurora in within the next 8-12 months.
https://finance.yahoo.com/news/organigram-enters-exclusive-partnership-oils-100000160.html
Recent ACB News
- Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products • PR Newswire (US) • 04/30/2024 11:15:00 AM
- Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products • PR Newswire (Canada) • 04/30/2024 11:15:00 AM
- Marijuana Stocks Up After Banking Reform Progress • IH Market News • 04/09/2024 10:05:42 AM
- Aurora Cannabis Commends Germany's Landmark Legalization Achievement • PR Newswire (US) • 04/01/2024 11:00:00 AM
- Aurora Cannabis Commends Germany's Landmark Legalization Achievement • PR Newswire (Canada) • 04/01/2024 11:00:00 AM
- Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance • PR Newswire (Canada) • 03/20/2024 11:15:00 AM
- Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance • PR Newswire (US) • 03/20/2024 11:15:00 AM
- Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia • PR Newswire (Canada) • 03/04/2024 02:42:00 PM
- Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia • PR Newswire (US) • 03/04/2024 02:42:00 PM
- Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1] • PR Newswire (Canada) • 02/29/2024 10:00:00 PM
- Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1] • PR Newswire (US) • 02/29/2024 10:00:00 PM
- Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis • PR Newswire (US) • 02/28/2024 12:13:00 PM
- Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis • PR Newswire (Canada) • 02/28/2024 12:11:00 PM
- Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis • PR Newswire (US) • 02/28/2024 12:11:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/20/2024 12:36:30 PM
- Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation • PR Newswire (Canada) • 02/20/2024 12:00:00 PM
- Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation • PR Newswire (US) • 02/20/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/16/2024 02:49:18 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/08/2024 12:23:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/08/2024 12:10:27 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/08/2024 12:07:18 PM
- Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million • PR Newswire (Canada) • 02/08/2024 12:00:00 PM
- Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million • PR Newswire (US) • 02/08/2024 12:00:00 PM
- Aurora Cannabis Acquires MedReleaf Australia • PR Newswire (US) • 02/08/2024 11:45:00 AM
- Aurora Cannabis Acquires MedReleaf Australia • PR Newswire (Canada) • 02/08/2024 11:45:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM